Skip to main content
Top
Published in: International Urology and Nephrology 2/2007

01-06-2007 | LETTER TO THE EDITOR

No effect of serum parathyroid hormone level on antigen presenting cell-dependent T-cell reactivity in hemodialysis patients

Authors: Theodoros Eleftheriadis, Vassilis Liakopoulos, Georgia Antoniadi, Antigoni Poultsidi, Alexandros Kortsaris, Ioannis Stefanidis, Vassilis Vargemezis

Published in: International Urology and Nephrology | Issue 2/2007

Login to get access

Excerpt

Sir, …
Literature
1.
go back to reference Rangel M, Coronado V, Euler G, Strikas R (2000) Vaccine recommendations for patients on chronic dialysis. Semin Dial 13:101–107PubMedCrossRef Rangel M, Coronado V, Euler G, Strikas R (2000) Vaccine recommendations for patients on chronic dialysis. Semin Dial 13:101–107PubMedCrossRef
2.
go back to reference Eleftheriadis T, Papazisis K, Kortsaris A et al (2004) Impaired T-cell proliferation and ζ-chain phosphorylation after stimulation with staphylococcal enterotoxin-B in haemodialysis patients. Nephron Clin Pract 96:c15–c20PubMedCrossRef Eleftheriadis T, Papazisis K, Kortsaris A et al (2004) Impaired T-cell proliferation and ζ-chain phosphorylation after stimulation with staphylococcal enterotoxin-B in haemodialysis patients. Nephron Clin Pract 96:c15–c20PubMedCrossRef
3.
go back to reference Tzanno-Martins C, Futata E, Jorgetti V, Duarte AJ (2000) Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared? Clin Nephrol 54(1):22–29PubMed Tzanno-Martins C, Futata E, Jorgetti V, Duarte AJ (2000) Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared? Clin Nephrol 54(1):22–29PubMed
4.
go back to reference Ori Y, Korzets A, Malachi T et al (1999) Impaired lymphocyte calcium metabolism in end-stage renal disease: enhanced influx, decreased efflux, and reduced response to mitogen. J Lab Clin Med 133(4):391–400PubMedCrossRef Ori Y, Korzets A, Malachi T et al (1999) Impaired lymphocyte calcium metabolism in end-stage renal disease: enhanced influx, decreased efflux, and reduced response to mitogen. J Lab Clin Med 133(4):391–400PubMedCrossRef
5.
go back to reference Fields BA, Malchiodi EL, Ysern X (1996) Crystal structure of a T cell receptor β chain complexed with a superantigen. Nature 383:188–192CrossRef Fields BA, Malchiodi EL, Ysern X (1996) Crystal structure of a T cell receptor β chain complexed with a superantigen. Nature 383:188–192CrossRef
6.
go back to reference Hayward AR, Herberger M (1987) Lymphocyte response to varicella zoster virus in the elderly. J Clin Immunol 7:174–178PubMedCrossRef Hayward AR, Herberger M (1987) Lymphocyte response to varicella zoster virus in the elderly. J Clin Immunol 7:174–178PubMedCrossRef
7.
go back to reference Krakauer T (1999) Immune response to staphylococcal superantigens. Immunol Res 20(2):163–173PubMed Krakauer T (1999) Immune response to staphylococcal superantigens. Immunol Res 20(2):163–173PubMed
Metadata
Title
No effect of serum parathyroid hormone level on antigen presenting cell-dependent T-cell reactivity in hemodialysis patients
Authors
Theodoros Eleftheriadis
Vassilis Liakopoulos
Georgia Antoniadi
Antigoni Poultsidi
Alexandros Kortsaris
Ioannis Stefanidis
Vassilis Vargemezis
Publication date
01-06-2007
Publisher
Kluwer Academic Publishers
Published in
International Urology and Nephrology / Issue 2/2007
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-006-9100-y

Other articles of this Issue 2/2007

International Urology and Nephrology 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine